A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Personalis, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 3,206 shares of PSNL stock, worth $19,524. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,206
Previous 3,206 -0.0%
Holding current value
$19,524
Previous $17,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$1.19 - $6.34 $1,354 - $7,214
-1,138 Reduced 26.2%
3,206 $17,000
Q2 2024

Jul 29, 2024

SELL
$1.17 - $1.65 $794 - $1,120
-679 Reduced 13.52%
4,344 $5,000
Q1 2024

Apr 25, 2024

SELL
$1.15 - $2.19 $192 - $365
-167 Reduced 3.22%
5,023 $7,000
Q4 2023

Jan 30, 2024

SELL
$0.93 - $2.35 $393 - $994
-423 Reduced 7.54%
5,190 $10,000
Q3 2023

Oct 25, 2023

SELL
$1.19 - $2.36 $565 - $1,121
-475 Reduced 7.8%
5,613 $6,000
Q2 2023

Aug 07, 2023

SELL
$1.8 - $3.19 $889 - $1,575
-494 Reduced 7.51%
6,088 $11,000
Q4 2022

Feb 01, 2023

SELL
$1.78 - $3.64 $58 - $120
-33 Reduced 0.5%
6,582 $13,000
Q3 2022

Nov 09, 2022

SELL
$2.89 - $5.32 $231 - $425
-80 Reduced 1.19%
6,615 $20,000
Q2 2022

Aug 09, 2022

SELL
$3.27 - $8.76 $20,316 - $54,425
-6,213 Reduced 48.13%
6,695 $23,000
Q1 2022

Apr 21, 2022

SELL
$7.56 - $14.3 $12,405 - $23,466
-1,641 Reduced 11.28%
12,908 $106,000
Q4 2021

Feb 01, 2022

BUY
$12.24 - $21.25 $35,079 - $60,902
2,866 Added 24.53%
14,549 $208,000
Q3 2021

Nov 15, 2021

SELL
$16.69 - $26.05 $33 - $52
-2 Reduced 0.02%
11,683 $225,000
Q2 2021

Jul 30, 2021

BUY
$18.15 - $27.75 $8,349 - $12,765
460 Added 4.1%
11,685 $296,000
Q1 2021

May 03, 2021

BUY
$20.71 - $51.02 $205,981 - $507,444
9,946 Added 777.64%
11,225 $276,000
Q4 2020

Jan 28, 2021

BUY
$21.84 - $44.0 $27,933 - $56,276
1,279 New
1,279 $47,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $280M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.